Using TRAF2 as a prognostic factor for PCa patients revealed that higher TRAF2 levels were associated with worse overall survival rate (p = 0.034, HR = 7) and disease-free survival rate (p = 0.00038, HR = 2.2) (Figure 2L). This evidence concerns the gene TRAF2 and posterior cortical atrophy.